State of the Arg Protein Methylation at Arginine Comes of Age by McBride, Anne E. & Silver, Pamela A.
Cell, Vol. 106, 5–8, July 13, 2001, Copyright 2001 by Cell Press
MinireviewState of the Arg:
Protein Methylation
at Arginine Comes of Age
residues in the 1 to 2 positions for recognition of the
substrate arginine (for a detailed compilation of methyl-
arginine contexts, see Gary and Clarke, 1998).
An Emerging Family of Arginine Methyltransferases
Recent interest in arginine methylation has been
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sparked by the identification of multiple arginine methyl-Dana-Farber Cancer Institute
transferase encoding genes. Although these genes haveBoston, Massachusetts 02115
been uncovered in a variety of screens designed to
identify proteins involved in different cellular processes
(see below), the most striking characteristic of thisPosttranslational modification of proteins allows the cell
emerging family of enzymes is the presence of an S-aden-to expand its repertoire beyond the constraints imposed
osyl methionine (AdoMet) binding motif (Figure 2A),by the twenty encoded amino acids. Methylation at argi-
which is closely related to the motif found in nucleicnines, although discovered over 30 years ago, has only
acid and small molecule methyltransferases that userecently come to the attention of cell biologists through
AdoMet as a methyl donor. In addition to the AdoMeta combination of genetic and molecular biology experi-
binding motif, four of five putative mammalian argininements that have implicated arginine methylation in pro-
methyltransferases studied to date also share a lesscesses from signaling and transcription activation to pro-
conserved C-terminal domain, which is presumably in-tein sorting. The panoply of arginine methylated substrates
volved in arginine substrate interactions.suggests that this specifically eukaryotic modification
The majority of arginine methylation in eukaryotic cellsmay parallel phosphorylation in its level of complexity.
appears to be performed by a specific methyltransferase
We will summarize much of the recent information about
subfamily, which includes mammalian PRMT1 and its
the function of methylation and the methyltransferase
functional homolog, yeast Hmt1/Rmt1. The enzymes in
enzymes that modify arginines.
this subfamily contain few residues outside the core
Many Proteins Are Targets of Arginine Methylation
region. In contrast, Carm1/PRMT4 contains both N- and
Three main forms of methylarginine have been identified
C-terminal extensions to the methyltransferase core re-
in eukaryotes: NG-monomethylarginine (MMA), NGNG gion. Other family members have N-terminal extensions,
(asymmetric) dimethylarginine (aDMA), and NGNG (sym- several of which contain additional motifs such as an
metric) dimethylarginine (sDMA), all of which involve SH3 domain (PRMT2) and a zinc finger motif (PRMT3).
modification of guanidino nitrogen atoms (Figure 1). Al- Whereas all arginine methyltransferase activities iden-
though early purification of mammalian protein arginine tified to date can monomethylate arginine in the context
methyltransferases used methylation of histones to of a protein substrate, methyltransferases have been
track activity, the majority of nuclear asymmetric di- classified as type I or type II enzymes according to
methylarginine residues are found in heterogeneous nu- whether further dimethylation is asymmetric (type I) or
clear ribonucleoproteins (hnRNPs), which play roles in symmetric (type II). Most PRMT genes discovered to
pre-mRNA processing and nucleocytoplasmic RNA date encode type I enzymes, but recent data have re-
transport. Subsequent work on numerous hnRNPs and vealed that PRMT5/JBP1 (Janus kinase binding protein
other RNA binding proteins has revealed that they are 1) is a type II methyltransferase (Branscombe et al.,
methylated on arginine residues, frequently in the con- 2001). Although in vivo substrates for the type I PRMT1/
text of RGG tripeptides. Notably, all methylarginine resi- Hmt1 enzymes have been defined, the substrate speci-
dues within RGG motifs have been shown to be MMA ficity of the majority of arginine methyltransferases re-
or aDMA rather than sDMA. Proteins have also been mains mysterious. In the case of PRMT3, however, its
identified that are asymmetrically dimethylated at RXR N-terminal zinc finger domain has been shown to influ-
and RG motifs. ence its substrate specificity (Frankel and Clarke, 2000).
Myelin basic protein, which was one of the first argi- The three-dimensional structures of the core regions
nine-methylated proteins identified, stands in contrast of yeast Hmt1 and human PRMT3 have been determined
to most methylated RNA binding proteins in that it con- by X-ray crystallography and a comparison of these
tains symmetrically dimethylated arginine residues in structures underscores the structural similarity between
addition to monomethylarginine. Recently, however, these enzymes (Figure 2B) (Weiss et al., 2000; Zhang et
two RNA binding proteins, spliceosomal snRNP proteins al., 2000). Whereas the AdoMet binding domains are
SmD1 and SmD3, have been shown to be symmetrically virtually superimposable, the C termini contain divergent
dimethylated (Brahms et al., 2000). Intriguingly, the con- loops, suggesting that this region is involved in interac-
tions with different methyltransferase substrates andtext of methylated residues in these proteins (GRG) dif-
regulators. The N termini are also variable and not com-fers from the original RGG consensus for asymmetrically
pletely resolved in the structures. Indeed, genetic anddimethylated proteins, suggesting the importance of
biochemical experiments in yeast, combined with the
Hmt1 crystal structure, have suggested a specific bind-1 Correspondence: anne_mcbride@dfci.harvard.edu [A.E.M.]; pamela_
ing pocket for its hnRNP substrate Npl3 that includessilver@dfci.harvard.edu [P.A.S.]
the N and C termini (Weiss et al., 2000). In addition,2 Present address: Department of Biology, Bowdoin College, Bruns-
wick, Maine 04011. PRMT3 was cocrystallized with the inhibitor S-adenosyl
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Figure 1. Arginine Methylation
Methylation of arginine residues within the
context of a protein requires the methyl donor
S-adenosyl methionine (AdoMet), which is
converted into S-adenosyl homocysteine
(AdoHcy).
homocysteine (AdoHcy), indicating the importance of effect on nonspecific binding to homopolymeric RNA
(Rajpurohit et al., 1994), methylation of yeast hnRNPan N-terminal X helix in stabilizing cofactor binding
(Zhang et al., 2000). Hrp1 did not affect its affinity for a specific RNA ligand
(Valentini et al., 1999). RGG motifs may play an auxiliaryOne remarkable feature of both crystal structures is
the presence of methyltransferase dimers and, in the role in RNA binding, since RGG proteins frequently con-
tain other RNA binding domains such as RNA-recogni-case of Hmt1, dimerization correlates with enzymatic
function (Weiss et al., 2000). The ability of these enzymes tion motifs (RRMs) or hnRNP K homology (KH) domains.
Instead, recent studies have implicated arginine methyl-to multimerize is tantalizing as it may reflect a mecha-
nism for regulation of methyltransferase activity (see ation in modulating protein-protein interactions. Sam68, a
mitotic substrate for the Src kinase, is thought to act asbelow). Future studies of cocrystallized methyltransfer-
ase-substrate pairs may also unveil specific interactions an adaptor protein in signaling pathways and binds to
both WW domain and SH3 domain-containing proteinsthat could clarify both the mechanism of methylation
and how it might be regulated. through proline-rich regions. Interestingly, methylation
of Sam68 at arginine residues within these regions de-Methylation Affects Protein-Protein Interactions
Although methylation does not change the overall creases Sam68 binding to SH3 proteins but not to WW
domain proteins (Bedford et al., 2000). These resultscharge on an arginine residue, addition of methyl groups
increases steric hindrance and removes amino hydro- suggest that methylation may be involved in switching
the function of Sam68 by altering specific protein-pro-gens that might be involved in hydrogen bonds. There-
fore, methylation could serve to modulate intra- or inter- tein contacts. Similarly, arginine methylation of the Stat1
(signal transducer and activator of transcription) tran-molecular interactions of target proteins. In spite of the
prevalence of RNA binding proteins with RGG motifs, scription factor decreases its affinity for its inhibitor
PIAS1 (Mowen et al., 2001). In contrast to these asym-few studies have directly addressed the effect of argi-
nine methylation on binding of target proteins to RNA metrically dimethylated proteins, SmD1 and SmD3 have
been shown to require symmetric dimethylation for effi-ligands. Although methylation of hnRNPA1 had a slight
Figure 2. The Structure of Protein Arginine
Methyltransferases
(A) Primary structure comparison. All family
members share a core arginine methyltrans-
ferase region, composed of a conserved Ado-
Met binding domain (red) and a more diver-
gent C-terminal domain (pink). Mammalian
methyltransferases (PRMT1-3, CARM1, and
JBP1) and S. cerevisiae Hmt1, the budding
yeast PRMT1 homolog, are shown.
(B) Comparison of the yeast Hmt1 and human
PRMT3 crystal structures. Arrowheads de-
note divergent loops in the C-terminal do-
mains of yeast Hmt1 and human PRMT3
methyltransferases. The carboxyl termini of
the two proteins are superimposed (C),
whereas the amino terminus of Hmt1 is un-
structured and that of PRMT3 contains an
additional X helix (N), which allows binding
of AdoHcy (shown in space-filling model).
Figure by V. Weiss from PDB files 1G6Q and
1F3L (Weiss et al., 2000; Zhang et al., 2000).
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protein (Pollack et al., 1999). However, it is not yet clear
whether these proteins or the symmetrically dimethyl-
ated Sm proteins are in vivo substrates of JBP1 or its
yeast homolog Hsl7 (histone synthetic lethal 7).
The identification of a coactivator-associated arginine
methyltransferase (Carm1) led to studies that showed
that this methyltransferase could stimulate transcrip-
tional activation by nuclear receptors in combination
with p160 family coactivators (Chen et al., 1999). PRMT1
has also been shown to have coactivator activity (Wang
et al., 2001). The abilities of Carm1 to methylate histone
H3 and of PRMT1 to methylate histone H4 suggest that
this posttranslational modification of histones may be
involved in transcriptional coactivation (Chen et al.,
1999; Wang et al., 2001). Indeed, mutations within the
AdoMet binding domain of both Carm1 and PRMT1 re-
duce both histone methylation and coactivator activities
Figure 3. Possible Cellular Roles of Arginine Methylation (Chen et al., 1999; Wang et al., 2001).
Arginine methyltransferases (RMT) have been implicated in signaling Can Methylation Be Regulatory?
by interactions with the interferon receptor (IFNR; Abramovich et al., Although it is tempting to compare protein methylation
1997), Janus kinase (JAK; Pollack et al., 1999), and Stat transcription to phosphorylation, arginine methylation is generally be-
factor (Mowen et al., 2001). Methyltransferase interactions with the
lieved to be irreversible. In the absence of an identifiedp160 family of transcriptional coactivators of nuclear hormone re-
arginine demethylase protein or enzymatic activity, theceptors (NR) have also suggested a role in gene expression (Chen et
increasing stability of the amine bond as arginine isal., 1999). Methylation of certain heterogeneous ribonucleoproteins
(hnRNPs) in yeast affects their nucleocytoplasmic transport (Shen mono- and then dimethylated suggests that this modifi-
et al., 1998; Yun and Fu, 2000). Methylation substrates are shown cation is likely to persist over the lifetime of a protein.
in blue. Therefore, regulation of arginine methylation would pre-
sumably occur at the level of modulating methyltransfer-
ase activity toward unmethylated substrates, by sequen-cient binding to SMN, the product of the spinal muscular
tially increasing the amount of methylation over theatrophy gene (Friesen et al., 2001). Therefore, although
lifetime of a protein, or by selective turnover of methyl-Sam68, Stat1, SmD1, and SmD3 are all nucleic-acid
ated proteins. Indeed, the first mammalian enzyme iden-binding proteins, methylation appears to affect their
tified, PRMT1, was discovered by virtue of its physicalbinding to protein partners in a nucleic-acid-indepen-
interaction with immediate-early protein TIS21 and thedent manner.
related BTG1 protein and these proteins were shown toRoles of Methylation: Protein Sorting,
modulate the activity and substrate specificity of PRMT1Transcription, and Signaling
(Lin et al., 1996). Many arginine methyltransferase genes
Whereas hnRNP proteins, myelin basic protein, and his-
have been cloned similarly in yeast two-hybrid screens
tones have long been known to be substrates for argi-
with a variety of proteins of interest, many of which are
nine methylation, the cellular processes affected by involved in cell signaling (e.g., PRMT1 [Abramovich et
methylation have only recently begun to be elucidated al., 1997], Carm1 [Chen et al., 1999], JBP1 [Pollack et
(Figure 3). Studies in Saccharyomyces cerevisiae re- al., 1999]). The plethora of methyltransferase-interacting
vealed that the yeast arginine methyltransferase Hmt1/ proteins likely includes both upstream regulators and
Rmt1 is critical for efficient nuclear export of its sub- downstream targets or effectors of arginine methyltrans-
strates, Npl3 and Hrp1 (Shen et al., 1998). Methylation ferases.
of Npl3 may also regulate its nuclear import (Yun and Fu, Methyltransferase activity may also be regulated by
2000). A null mutation in mouse PRMT1, the mammalian self-association or interaction with other methyltransfer-
homolog of Hmt1, resulted in embryonic lethality, al- ase family members. Although PRMT3 was initially iden-
though embryonic stem cells bearing this mutation were tified as a PRMT1-interacting protein and the PRMT3
viable (Pawlak et al., 2000), suggesting the importance core crystal structure revealed a dimer interface, PRMT3
of PRMT1 in basic cellular processes. itself does not appear to dimerize in mammalian cell
Arginine methyltransferases have also been impli- lysates (Tang et al., 1998). In contrast, yeast Hmt1 and
cated in signal transduction. PRMT1 binds to the cyto- its mammalian homolog PRMT1 both oligomerize in cell
plasmic domain of the type I interferon receptor (Abra- lysates, and mutations that disrupt dimerization of Hmt1
movich et al., 1997), and methylation of a conserved eliminate its activity in vivo (Tang et al., 1998; Weiss et
arginine in the Stat1 transcription factor was shown to be al., 2000). The reduced activity of PRMT3 compared to
essential for interferon /-induced signaling (Mowen PRMT1 in vitro may reflect a role for multimerization in
et al., 2001). Interestingly, the most divergent putative regulation of PRMT3 enzymatic function, perhaps de-
arginine methyltransferase family member, PRMT5/ pendent on specific cellular environments.
JBP1, was identified by its interaction with the Janus Protein Methylation and Disease
kinase, which is required for signaling between the inter- Methylarginine and methylated proteins have been con-
feron receptor and Stats (Pollack et al., 1999). JBP1 nected to a number of diseases. Monomethylarginine
binds AdoMet and, when isolated from cell lysates, can and asymmetric dimethylarginine are potent inhibitors
of nitric oxide synthase (NOS), and increased levels ofmethylate histones H2A and H4 as well as myelin basic
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Wang, H., Huang, Z.Q., Xia, L., Feng, Q., Erdjument-Bromage, H.,these species have been found in patients with various
Strahl, B.D., Briggs, S.D., Allis, C.D., Wong, J., Tempst, P., andcardiovascular and noncardiovascular disorders. The
Zhang, Y. (2001). Science 31, 31.likely irreversible nature of arginine methylation raises
Weiss, V.H., McBride, A.E., Soriano, M.A., Filman, D.J., Silver, P.A.,the possibility that protein arginine methylation and sub-
and Hogle, J.M. (2000). Nat. Struct. Biol. 7, 1165–1171.
sequent metabolism of target proteins may influence
Yun, C.Y., and Fu, X.D. (2000). J. Cell Biol. 150, 707–718.
NOS activity.
Zhang, X., Zhou, L., and Cheng, X. (2000). EMBO J. 19, 3509–3519.Several targets for arginine methylation have been
implicated in autoimmune diseases. Anti-myelin basic
protein antibodies have been found in multiple sclerosis
(MS) patients and, in a mouse model for MS, myelin basic
protein provokes an autoimmune response. In addition,
multiple ribonucleoproteins, many of which are methyl-
ated, have been found as antigens in autoimmune dis-
eases. In particular, epitopes recognized by anti-Sm
autoantibodies in lupus erythematosis patients include
symmetrical dimethylarginines in SmD1 and SmD3
(Brahms et al., 2000).
Conclusions
The recent identification of multiple arginine methyl-
transferase family members and targets for arginine
methylation has implicated protein methylation in a vari-
ety of cellular processes from signaling to protein trans-
port. The full characterization of each methyltransferase
and its in vivo substrates will serve as a next step in
understanding the role of arginine methylation in eukary-
otes. In addition, specific inactivation of particular en-
zymes may facilitate experiments to define how methyl-
ation affects target proteins, including, for example, their
protein-protein interactions. Such studies will address
the importance of methylation for protein function and
may therefore eventually lead to new insights into dis-
ease processes.
Selected Reading
Abramovich, C., Yakobson, B., Chebath, J., and Revel, M. (1997).
EMBO J. 16, 260–266.
Bedford, M.T., Frankel, A., Yaffe, M.B., Clarke, S., Leder, P., and
Richard, S. (2000). J. Biol. Chem. 275, 16030–16036.
Brahms, H., Raymackers, J., Union, A., de Keyser, F., Meheus, L.,
and Luhrmann, R. (2000). J. Biol. Chem. 275, 17122–17129.
Branscombe, T.L., Frankel, A., Lee, J.H., Cook, J.R., Yang Zh, Z.,
Pestka, S., and Clarke, S. (2001). J. Biol. Chem. 18, in press.
Chen, D., Ma, H., Hong, H., Koh, S.S., Huang, S.M., Schurter, B.T.,
Aswad, D.W., and Stallcup, M.R. (1999). Science 284, 2174–2177.
Frankel, A., and Clarke, S. (2000). J. Biol. Chem. 275, 32974–32982.
Friesen, W.J., Massenet, S., Paushkin, S., Wyce, A., and Dreyfuss,
G. (2001). Mol. Cell 7, 1111–1117.
Gary, J.D., and Clarke, S. (1998). Prog. Nucleic Acid Res. Mol. Biol.
61, 65–131.
Lin, W.J., Gary, J.D., Yang, M.C., Clarke, S., and Herschman, H.R.
(1996). J. Biol. Chem. 271, 15034–15044.
Mowen, K.A., Tang, J., Zhu, W., Schurter, B.T., Shuai, K., Herschman,
H.R., and David, M. (2001). Cell 104, 731–741.
Pawlak, M.R., Scherer, C.A., Chen, J., Roshon, M.J., and Ruley, H.E.
(2000). Mol. Cell. Biol. 20, 4859–4869.
Pollack, B.P., Kotenko, S.V., He, W., Izotova, L.S., Barnoski, B.L.,
and Pestka, S. (1999). J. Biol. Chem. 274, 31531–31542.
Rajpurohit, R., Paik, W.K., and Kim, S. (1994). Biochem. J. 304,
903–909.
Shen, E.C., Henry, M.F., Weiss, V.H., Valentini, S.R., Silver, P.A., and
Lee, M.S. (1998). Genes Dev. 12, 679–691.
Tang, J., Gary, J.D., Clarke, S., and Herschman, H.R. (1998). J. Biol.
Chem. 273, 16935–16945.
Valentini, S.R., Weiss, V.H., and Silver, P.A. (1999). RNA 5, 272–280.
